PPP
NZDUSD OverBought Fundamentally and Technically NZD/USD has slightly overshot its PPP implied exchange rate and the RSI(14) is at yearly highs (so is the price as well). I expect at least a small correction as traders wait for more economic data to justify a further move to the upside as this is a riskier asset. Disclaimer: As always, I am not your financial advisor.
PPP - The un-famous potential winnerDespite the market’s declination , PPP is still holding a strong-looking bullish flag daily chart.
PPP has a ok fundamental and did the breakout with some volume.
You can see from the history that I like to trade near-2.00-price stocks.
This one also, as long as it stays above the moving average, I will hold it.
From its performance, we can assume that there is no seller left.
PPP- Bump & run formation Long from EMA9 to $1.27 PPP looks quite solid in technical & fundamental, and it had a big run in last 2 day. Now we are looking for a long if it pools back to EMA.
* Trade Criteria *
Date first found-February 7, 2017
Pattern/Why- Bump & run formation
Entry Target Criteria- Pull back to EMA 9 ($0.85)
Exit Target Criteria- $1.27 & higher
Stop Loss Criteria- $0.74
(Note: Trade update is delayed here.)
DSKX Begins To Rally After The Conference CallShares of DSKX continues to rally from last week after they held a conference call to discuss the recently announced agreement to acquire Radiancy, Inc., a leading developer of consumer medical devices and the Neova® dermatological products.
It appears investors are beginning to notice the financial value this new deal brings and the future outlook of the company, so if you haven't already, I highly encourage you to listen to today's conference call as soon as possible. Much larger company structure overall, significant increase in revenue, assets, cash flow and working capital with a very reputable management team to move the company forward. The fact that the current market cap is only 33M is what really gets me excited. Listen to the call to learn more:
The replay of the conference call can be heard by dialing 1-888-286-8010 in the United States and Canada or +1-617-801-6888 internationally, then referencing the Conference Passcode "56187013" A recording of the call can also be heard on the company website.
In the call, the DS Healthcare Group management team shared their motivations and answered questions relating to the business fundamentals on the Radiancy & Neova® deal, explaining how natural strategy alignment and synergies will lead to significant bottom line contribution.
The call was hosted by Mark Brockelman (CFO), Manny Gonzeles (CCO) and Renee Barch-Niles (CEO) and took place on Thursday, February 25th, 2016, at 8:30 a.m. EST.
-Renee Barch-Niles (CEO), an experienced CPG Executive who drove double-digit year-over-year growth in global food, drug, mass, club and specialty channels for Global companies such as Daymon Worldwide and Emilia Personal Care.
-Mark Brockelman (CFO) who has great experience in mergers and acquisitions, systems integration expertise and highly astute financial acumen. Mr. Brockelman Brockelman served as the Chief Financial Officer for National Dentex Corporation as well as the Senior Vice President/Chief Financial and Administrative Officer of the Miami Dolphins.
-Manny Gonzalez (CCO), a former top (NASDAQ: PG) Procter & Gamble executive managing a team of 7,000 sales representatives in the U.S., who has direct access to every major retailer in the country.
Acquisition Press Release Below:
finance.yahoo.com
For full disclose please visit: www.stockpicksnyc.com